HomeARCH • CVE
add
Arch Biopartners Inc
Previous close
$1.84
Day range
$1.83 - $1.94
Year range
$1.36 - $2.56
Market cap
122.58M CAD
Avg Volume
11.75K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | -360.66K | 67.18% |
Operating expense | 3.91M | 1,762.52% |
Net income | -1.10M | -551.92% |
Net profit margin | 306.10 | 1,476.97% |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.97K | -99.64% |
Total assets | 935.62K | -20.11% |
Total liabilities | 5.28M | -20.92% |
Total equity | -4.35M | — |
Shares outstanding | 60.77M | — |
Price to book | -26.29 | — |
Return on assets | -204.64% | — |
Return on capital | 180.18% | — |
Cash Flow
Net change in cash
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -1.10M | -551.92% |
Cash from operations | -469.84K | 45.07% |
Cash from investing | — | — |
Cash from financing | 428.87K | 48.12% |
Net change in cash | -40.98K | 92.76% |
Free cash flow | -383.49K | 35.41% |
About
Founded
1983
Headquarters
Website
